CBE ID
2525
Project
Endorsed
New or Maintenance
Endorsement and Maintenance (E&M) Cycle
Is Under Review
No
Measure Description
Percentage of patients 18 years and older with a diagnosis of rheumatoid arthritis who are newly prescribed disease modifying anti-rheumatic drug (DMARD) therapy within 12 months.
- Measure TypeElectronic Clinical Quality Measure (eCQM)Level Of AnalysisCare SettingNumerator
Patient received a DMARD
DenominatorPatient age 18 years and older with a diagnosis of rheumatoid arthritis seen for two or more face-to-face encounters for RA with the same clinician during the measurement period
ExclusionsPatients with a diagnosis of HIV; patients who are pregnant; or patients with inactive Rheumatoid Arthritis.
Testing Data Sources
- Measure StructureClinical Condition Topic AreaMeasure Selection AttributesNational Quality Strategy PrioritiesClinical Preventive ServicesPrevention and Treatment
- Risk Adjustment
- Current or planned use(s)Current Use(s)
- Most Recent Endorsement ActivityApproved for Trial Use Primary Care and Chronic Illness Spring Cycle 2019Initial EndorsementNext Planned Maintenance ReviewPrimary Care and Chronic Illness Fall 2023Endorsement StatusLast Updated
- StewardSteward Organization EmailSteward Organization Copyright
Copyright (c) 2013, American College of Rheumatology